SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Ultragenyx Pharma maintained Buy rating by TD Cowen

TD Cowen maintained a Buy rating on Ultragenyx Pharma, according to Benzinga ratings actions via TradingView News.

RARE

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories